Retinal vein occlusion in COVID-19: A novel entity.
Administration, Oral
Angiogenesis Inhibitors
/ therapeutic use
Betacoronavirus
/ pathogenicity
COVID-19
Coronavirus Infections
/ diagnosis
Drug Therapy, Combination
Eye Infections, Viral
/ diagnosis
Fluorescein Angiography
Glucocorticoids
/ therapeutic use
Humans
Intravitreal Injections
Male
Methylprednisolone
/ therapeutic use
Middle Aged
Pandemics
Pneumonia, Viral
/ diagnosis
Ranibizumab
/ therapeutic use
Retinal Vasculitis
/ diagnosis
Retinal Vein Occlusion
/ diagnosis
SARS-CoV-2
Tomography, Optical Coherence
Vascular Endothelial Growth Factor A
/ antagonists & inhibitors
COVID-19
SARS-CoV-2
retinal vein occlusion
vasculitis
Journal
Indian journal of ophthalmology
ISSN: 1998-3689
Titre abrégé: Indian J Ophthalmol
Pays: India
ID NLM: 0405376
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
entrez:
25
9
2020
pubmed:
26
9
2020
medline:
3
10
2020
Statut:
ppublish
Résumé
Coronavirus disease 2019 (COVID-19) is a form of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has been declared a pandemic by the World Health Organization (WHO). Ocular manifestations related to COVID-19 are uncommon with conjunctivitis being reported in a few cases. We report a unique case of vasculitic retinal vein occlusion (RVO) secondary to COVID-19 in a 52-year-old patient who presented with the diminution of vision in the left eye 10 days after he tested positive for SARS-CoV-2. All investigations for vasculitis were negative. This case supports the mechanism of thrombo-inflammatory state secondary to the "cytokine-storm" as the pathogenesis for systemic manifestations of COVID-19.
Identifiants
pubmed: 32971697
pii: IndianJOphthalmol_2020_68_10_2291_295726
doi: 10.4103/ijo.IJO_2380_20
pmc: PMC7727974
doi:
Substances chimiques
Angiogenesis Inhibitors
0
Glucocorticoids
0
VEGFA protein, human
0
Vascular Endothelial Growth Factor A
0
Methylprednisolone
X4W7ZR7023
Ranibizumab
ZL1R02VT79
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2291-2293Commentaires et corrections
Type : CommentIn
Déclaration de conflit d'intérêts
None
Références
Lancet. 2020 May 23;395(10237):1610
pubmed: 32405105
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Am J Ophthalmol. 2007 Oct;144(4):552-6
pubmed: 17692276
J Thromb Haemost. 2020 May;18(5):1094-1099
pubmed: 32220112
N Engl J Med. 2020 Jul 17;:
pubmed: 32678530
Emerg Infect Dis. 2006 Feb;12(2):285-9
pubmed: 16494756
Ocul Immunol Inflamm. 2020 Jul 3;28(5):721-725
pubmed: 32469258
Int J Antimicrob Agents. 2020 Mar;55(3):105924
pubmed: 32081636
Int J Retina Vitreous. 2016 Jan 20;2:1
pubmed: 27847619
Eye (Lond). 2020 Dec;34(12):2153-2154
pubmed: 32647303